ArticleAcademia oncology2025
MicroRNA-mediated regulation of autophagy in lung cancer: role in tumourigenesis and chemotherapy resistance.
Article in Academia oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Autophagy is an evolutionarily conserved catabolic process that enables cells to degrade and recycle long-lived proteins and damaged organelles, playing an important role in cellular homeostasis and survival under stress. In lung cancer, autophagy has emerged as a key modulator of tumour cell survival and is a significant factor influencing chemotherapy efficacy. However, the contribution of autophagy to chemoresistance remains complex and incompletely understood. Recent studies identify microRNA (miRNAs), a class of small non-coding RNAs, as critical regulators of autophagy, capable of modulating autophagy-related genes and signalling pathways. Through this regulatory capacity, miRNAs can alter autophagic activity in lung cancer cells, thereby influencing both chemosensitivity and the development of chemoresistance. This review summarises current advances in the understanding of the miRNA-mediated regulation of autophagy in the context of lung cancer, with particular emphasis on its impact on chemotherapy response. Mechanistic insights into how miRNAs govern specific stages of the autophagic process are examined, and the potential for therapeutic intervention targeting the miRNA-autophagy axis to mitigate chemoresistance in lung cancer is discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.